Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study
Te Riele, J
MetadataShow full item record
JournalLancet Respiratory Medicine
AbstractAddition of bedaquiline to treatment for multidrug-resistant tuberculosis was associated with an increased risk of death in a phase 2b clinical trial, resulting in caution from WHO. Following a compassionate access programme and local regulatory approval, the South African National Tuberculosis Programme began widespread use of bedaquiline in March, 2015, especially among patients with extensively drug resistant tuberculosis for whom no other effective treatment options were available. We aimed to compare mortality in patients on standard regimens with that of patients on regimens including bedaquiline.